Drug factory · FDA FEI 3002996751

Konapharma AG

Im Wannenboden 16, Pratteln, Switzerland

Switzerland: 1

Problems found, fixed voluntarily at FDA's last inspection, Jun 19, 2024.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

5 drug inspections on record since 2009: 2 with no problems, 3 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
PonesimodMakes it Janssen Pharmaceuticals, Inc. 50458-707, 50458-720
SelexipagMakes it Actelion Pharmaceuticals US, Inc. 66215-718

FDA inspection history

EndedResultProgramProblems noted
Jun 19, 2024Problems found, fixed voluntarilyDrug Quality Assurance—
Jun 22, 2018Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 22, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
Apr 17, 2013No problems foundDrug Quality Assurance—
Sep 15, 2009No problems foundDrug Quality Assurance—

Registered with FDA for: manufacture.